BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30973654)

  • 1. RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy.
    Mini E; Lapucci A; Perrone G; D'Aurizio R; Napoli C; Brugia M; Landini I; Tassi R; Picariello L; Simi L; Mancini I; Messerini L; Magi A; Pinzani P; Mazzei T; Tonelli F; Nobili S
    Int J Cancer; 2019 Nov; 145(9):2580-2593. PubMed ID: 30973654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer.
    Dienstmann R; Villacampa G; Sveen A; Mason MJ; Niedzwiecki D; Nesbakken A; Moreno V; Warren RS; Lothe RA; Guinney J
    Ann Oncol; 2019 Oct; 30(10):1622-1629. PubMed ID: 31504112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer.
    Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A
    Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recurrence-predictive model based on eight genes and tumor mutational burden/microsatellite instability status in Stage II/III colorectal cancer.
    Gao Z; Wan Z; Yu P; Shang Y; Zhu G; Jiang H; Chen Y; Wang S; Lei F; Huang W; Zeng Q; Wang Y; Rong W; Hong Y; Gao Q; Niu P; Zhai Z; An K; Ding C; Wang Y; Gu G; Wang X; Meng Q; Ye S; Liu H; Gu J
    Cancer Med; 2024 Jan; 13(1):e6720. PubMed ID: 38111983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative genomic signatures in young and old Chinese patients with colorectal cancer.
    Wang F; Cheng H; Zhang X; Shan L; Bai B; Chen K; Lou F; Cao S; Wang H; Dai S
    Cancer Med; 2021 Jul; 10(13):4375-4386. PubMed ID: 34041865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Ligand-Receptor Perturbations Unravel MEIS2 as a Key Factor for the Aggressive Progression and Prognosis in Stage II/III Colorectal Cancer.
    Xu H; Chen S; Li J; Weng S; Ren Y; Zhang Y; Wang L; Liu L; Guo C; Xing Z; Luo P; Cheng Q; Han X; Liu Z
    J Proteome Res; 2024 Feb; 23(2):760-774. PubMed ID: 38153233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.
    Kleppe A; Skrede OJ; De Raedt S; Hveem TS; Askautrud HA; Jacobsen JE; Church DN; Nesbakken A; Shepherd NA; Novelli M; Kerr R; Liestøl K; Kerr DJ; Danielsen HE
    Lancet Oncol; 2022 Sep; 23(9):1221-1232. PubMed ID: 35964620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer.
    Bergsland CH; Bruun J; Guren MG; Svindland A; Bjørnslett M; Smeby J; Hektoen M; Kolberg M; Domingo E; Pellinen T; Tomlinson I; Kerr D; Church DN; Nesbakken A; Sveen A; Lothe RA
    ESMO Open; 2020 Nov; 5(6):e001040. PubMed ID: 33219056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modular and mechanistic changes across stages of colorectal cancer.
    Rahiminejad S; Maurya MR; Mukund K; Subramaniam S
    BMC Cancer; 2022 Apr; 22(1):436. PubMed ID: 35448980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer.
    Salvucci M; Würstle ML; Morgan C; Curry S; Cremona M; Lindner AU; Bacon O; Resler AJ; Murphy ÁC; O'Byrne R; Flanagan L; Dasgupta S; Rice N; Pilati C; Zink E; Schöller LM; Toomey S; Lawler M; Johnston PG; Wilson R; Camilleri-Broët S; Salto-Tellez M; McNamara DA; Kay EW; Laurent-Puig P; Van Schaeybroeck S; Hennessy BT; Longley DB; Rehm M; Prehn JH
    Clin Cancer Res; 2017 Mar; 23(5):1200-1212. PubMed ID: 27649552
    [No Abstract]   [Full Text] [Related]  

  • 11. Integration of single-cell sequencing and bulk RNA-seq to identify and develop a prognostic signature related to colorectal cancer stem cells.
    Wu J; Li W; Su J; Zheng J; Liang Y; Lin J; Xu B; Liu Y
    Sci Rep; 2024 May; 14(1):12270. PubMed ID: 38806611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry.
    Trinh A; Trumpi K; De Sousa E Melo F; Wang X; de Jong JH; Fessler E; Kuppen PJ; Reimers MS; Swets M; Koopman M; Nagtegaal ID; Jansen M; Hooijer GK; Offerhaus GJ; Kranenburg O; Punt CJ; Medema JP; Markowetz F; Vermeulen L
    Clin Cancer Res; 2017 Jan; 23(2):387-398. PubMed ID: 27459899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL-2 system analysis identifies high-risk colorectal cancer patients.
    Lindner AU; Salvucci M; Morgan C; Monsefi N; Resler AJ; Cremona M; Curry S; Toomey S; O'Byrne R; Bacon O; Stühler M; Flanagan L; Wilson R; Johnston PG; Salto-Tellez M; Camilleri-Broët S; McNamara DA; Kay EW; Hennessy BT; Laurent-Puig P; Van Schaeybroeck S; Prehn JHM
    Gut; 2017 Dec; 66(12):2141-2148. PubMed ID: 27663504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic landscape of early age onset of colorectal cancer identifies novel genes and pathways in Indian CRC patients.
    Singh MP; Rai S; Singh NK; Srivastava S
    Sci Rep; 2021 Jun; 11(1):11765. PubMed ID: 34083590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem Cell Marker Expression in Early Stage Colorectal Cancer is Associated with Recurrent Intestinal Neoplasia.
    Walker BS; Zarour LR; Wieghard N; Gallagher AC; Swain JR; Weinmann S; Lanciault C; Billingsley K; Tsikitis VL; Wong MH
    World J Surg; 2020 Oct; 44(10):3501-3509. PubMed ID: 32647988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor prognosis of young male patients with stage III colorectal cancer: A multicenter retrospective study.
    Okamoto K; Sasaki K; Nozawa H; Murono K; Emoto S; Yamauchi S; Sugihara K; Ishihara S
    J Surg Oncol; 2024 Mar; 129(4):785-792. PubMed ID: 38115553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using machine learning approach for screening metastatic biomarkers in colorectal cancer and predictive modeling with experimental validation.
    Ahmadieh-Yazdi A; Mahdavinezhad A; Tapak L; Nouri F; Taherkhani A; Afshar S
    Sci Rep; 2023 Nov; 13(1):19426. PubMed ID: 37940644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between adjuvant therapy and survival in colorectal cancer patients according to metabolic Warburg-subtypes.
    Offermans K; Jenniskens JCA; Simons CCJM; Samarska I; Fazzi GE; Smits KM; Schouten LJ; Weijenberg MP; Grabsch HI; van den Brandt PA
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6271-6282. PubMed ID: 36723668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer: results from the VICTOR trial.
    McGregor MJ; Fadhil W; Wharton R; Yanagisawa Y; Presz M; Pritchard A; Womack C; Dutton S; Kerr RS; Kerr DJ; Johnstone EC; Ilyas M
    Anticancer Res; 2015 Mar; 35(3):1641-5. PubMed ID: 25750322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
    Sirinukunwattana K; Domingo E; Richman SD; Redmond KL; Blake A; Verrill C; Leedham SJ; Chatzipli A; Hardy C; Whalley CM; Wu CH; Beggs AD; McDermott U; Dunne PD; Meade A; Walker SM; Murray GI; Samuel L; Seymour M; Tomlinson I; Quirke P; Maughan T; Rittscher J; Koelzer VH;
    Gut; 2021 Mar; 70(3):544-554. PubMed ID: 32690604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.